Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Terminated 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lung Neoplasms 2Urinary Bladder Neoplasms 1Terminal Cancer 1Solid Tumor 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Cognitive Complications 1Polyps 1Patient Satisfaction 1Pancreatitis 1Pancreatic Neoplasms 1Pain, Postoperative 1Pain 1Mouth Neoplasms 1Gastrointestinal Stromal Tumors 1Fractures, Bone 1Colonic Neoplasms 1Choledocholithiasis 1Choledochal Cyst 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Anxiety Disorders 1

Interventions

Cognitive Behavioral Therapy 2Oxygen 1Nitrous Oxide 1Music Therapy 1Midazolam 1Ketamine 1Hepatitis B Vaccines 1Gabapentin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Anxiety Disorders × Midazolam × Clear all
NCT03043430 2023-04-25

Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients

Brooke Army Medical Center

Phase 4 Terminated
10 enrolled
LymphoidOther hematologic neoplasm

Anxiety Disorders, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡